Bots, editor, reviewer, Administrators
13,951
edits
No edit summary |
No edit summary |
||
Line 3,462: | Line 3,462: | ||
}, | }, | ||
{ | { | ||
"timestamp" : " | "timestamp" : "2024-10-03T18:39:58Z", | ||
"briefDesignDescription" : "Edoxaban vs. warfarin in AF", | "briefDesignDescription" : "Edoxaban vs. warfarin in AF", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1310907", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1310907", | ||
Line 3,517: | Line 3,517: | ||
"title" : "Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction", | "title" : "Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction", | ||
"pmid" : "12668699" | "pmid" : "12668699" | ||
}, | |||
{ | |||
"timestamp" : "2024-10-03T19:17:59Z", | |||
"briefDesignDescription" : "Edoxaban±antiplatelet in AF+stable CAD", | |||
"fulltexturl" : "https://www.nejm.org/doi/10.1056/NEJMoa2407362", | |||
"pageid" : 5576, | |||
"pdfurl" : "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2407362", | |||
"trainingLevel" : "resident", | |||
"citation" : "Choo MS, <i>et al</i>. \"Edoxaban antithrombotic therapy for atrial fibrillation and stable coronary artery disease\". <i>The New England Journal of Medicine</i>. 2024. 1-13.", | |||
"subspecialties" : "Cardiology", | |||
"expansion" : "Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease", | |||
"statusUsableDate" : "2024-09-29", | |||
"briefResultsDescription" : "Edoxaban monotherapy has lower bleeding events in AF+stable CAD", | |||
"published" : "2024-09-01", | |||
"pageName" : "EPIC-CAD", | |||
"diseases" : "Coronary Artery Disease;Atrial Fibrillation", | |||
"abbreviation" : "EPIC-CAD", | |||
"title" : "Edoxaban antithrombotic therapy for atrial fibrillation and stable coronary artery disease", | |||
"pmid" : "39225258" | |||
}, | }, | ||
{ | { |